Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosphorylase kinase purified from rabbit skeletal muscle was ADP-ribosylated by hen liver nuclear
ADP-ribosyltransferase
. This modification, as was seen in cAMP-dependent phosphorylation, was observed only in alpha and beta subunits of the
phosphorylase kinase
and the latter was more rapidly modified. Analysis of the ADP-ribosylated amino acid residue sequenced in alpha and beta subunits showed that both subunits were modified at the area of the arginine residue. The Km for NAD was 0.10 mM and the pH optimum was 9.0. When the ADP-ribosylated
phosphorylase kinase
was phosphorylated by cAMP-dependent protein kinase, a reduction in phosphate incorporation occurred with increase in the ADP-ribosylation. ADP-ribosylation also suppressed autophosphorylation, to a lesser degree than observed with cAMP-dependent phosphorylation. The ADP-ribosylation-dependent reduction of phosphorylation resulted in a suppression of the phosphorylation-dependent activation of the
phosphorylase kinase
. These results together with findings of
ADP-ribosyltransferase
activity in the rabbit skeletal muscle [Soman, G. et al. (1984) Biochem. Biophys. Res. Commun. 120, 973-980] suggest that ADP-ribosylation participates in the regulation of the
phosphorylase kinase
activity through changes in the rate of phosphorylation.
...
PMID:ADP-ribosylation of phosphorylase kinase and block of phosphate incorporation into the enzyme. 298 11